Concentra: An Interesting IPO, Certainly For Its Parent Company
Concentra Group Holdings Parent, Inc. shares went public in an atypical offering, with a minority stake floated by parent company Select Medical Corporation. Concentra is the largest provider of occupational health services in the US, operating 547 centers, while treating over 50,000 patients daily. It appears that its parent company, Select Medical stands to benefit the most from this offering, and might be the most interesting investment opportunity.
Select Medical (SEM) Q2 Earnings and Revenues Top Estimates
Select Medical (SEM) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.61 per share a year ago.
Is Select Medical (SEM) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares
Select Medical's (SEM) subsidiary, Concentra, starts roadshow for IPO of 22.5 million shares, aiming to list on the NYSE under ticker "CON" with an expected price range of $23-$26 per share.
Select Medical (SEM) Expands Rehabilitation Services in Central PA
Select Medical (SEM) and UPMC unveil a 20-bed satellite facility of Helen M. Simpson Rehabilitation Hospital in West Shore, thus enhancing specialized inpatient rehabilitation care in Central Pennsylvania.
Here's Why Select Medical (SEM) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Select Medical (SEM) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?
Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.
Here's Why Select Medical (SEM) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Select Medical (SEM) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Q2 2024 EPS Estimates for Select Medical Holdings Co. Decreased by Zacks Research (NYSE:SEM)
Select Medical Holdings Co. (NYSE:SEM – Free Report) – Zacks Research lowered their Q2 2024 earnings per share (EPS) estimates for shares of Select Medical in a research note issued on Thursday, May 16th. Zacks Research analyst Z. Masood now expects that the health services provider will post earnings per share of $0.59 for the quarter, down from their previous forecast of $0.61. The consensus estimate for Select Medical’s current full-year earnings is $2.10 per share. Zacks Research also issued estimates for Select Medical’s FY2024 earnings at $2.19 EPS. Select Medical (NYSE:SEM – Get Free Report) last posted its quarterly earnings results on Friday, February 23rd. The health services provider reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. The business had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company posted $0.22 earnings per share. Select Medical’s quarterly revenue was up 4.9% on a year-over-year basis. Other equities research analysts also recently issued reports about the stock. Royal Bank of Canada lifted their price target on shares of Select Medical from $36.00 to $40.00 and gave the company an “outperform” rating in a research report on Monday, May 6th. Benchmark reiterated a “buy” rating and issued a $39.00 price target on shares of Select Medical in a research report on Friday, May 3rd. Finally, StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, March 22nd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $34.25. Read Our Latest Stock Report on SEM Select Medical Trading Down 0.8 % Shares of SEM stock opened at $33.95 on Monday. The firm has a 50 day moving average price of $29.58 and a two-hundred day moving average price of $26.66. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30. The company has a market capitalization of $4.41 billion, a PE ratio of 16.17, a price-to-earnings-growth ratio of 1.33 and a beta of 1.38. Select Medical has a 12-month low of $21.28 and a 12-month high of $35.08. Select Medical Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 30th. Investors of record on Thursday, May 16th will be paid a $0.125 dividend. The ex-dividend date of this dividend is Wednesday, May 15th. This represents a $0.50 annualized dividend and a dividend yield of 1.47%. Select Medical’s dividend payout ratio is 23.81%. Insider Buying and Selling In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the business’s stock in a transaction on Monday, April 8th. The shares were sold at an average price of $29.90, for a total value of $1,495,000.00. Following the sale, the chairman now owns 6,689,668 shares of the company’s stock, valued at $200,021,073.20. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 19.14% of the stock is currently owned by insiders. Institutional Trading of Select Medical Institutional investors have recently bought and sold shares of the company. Allspring Global Investments Holdings LLC raised its holdings in shares of Select Medical by 6.6% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after acquiring an additional 405 shares during the last quarter. Watershed Asset Management L.L.C. raised its holdings in shares of Select Medical by 8.2% in the 4th quarter. Watershed Asset Management L.L.C. now owns 10,760 shares of the health services provider’s stock worth $253,000 after acquiring an additional 814 shares during the last quarter. Paralel Advisors LLC grew its position in Select Medical by 1.1% in the 3rd quarter. Paralel Advisors LLC now owns 73,981 shares of the health services provider’s stock worth $1,870,000 after purchasing an additional 836 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Select Medical by 1.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 47,310 shares of the health services provider’s stock worth $1,112,000 after purchasing an additional 858 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new stake in Select Medical in the 3rd quarter worth about $29,000. Institutional investors own 89.48% of the company’s stock. About Select Medical (Get Free Report) Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. See Also Five stocks we like better than Select Medical What Are Dividend Contenders? Investing in Dividend Contenders MarketBeat Week in Review – 5/13 – 5/17 Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? Take-Two Interactive Software Offers 2nd Chance for Investors How to Invest in Small Cap Stocks Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
